Journey Medical Corporati... (DERM)
NASDAQ: DERM
· Real-Time Price · USD
6.73
-0.05 (-0.74%)
At close: Jun 16, 2025, 3:59 PM
6.74
0.13%
After-hours: Jun 16, 2025, 04:06 PM EDT
-0.74% (1D)
| Bid | 6.67 |
| Market Cap | 156.59M |
| Revenue (ttm) | 56.24M |
| Net Income (ttm) | -8.3M |
| EPS (ttm) | -0.37 |
| PE Ratio (ttm) | -18.19 |
| Forward PE | 7.73 |
| Analyst | Buy |
| Ask | 7.9 |
| Volume | 49,232 |
| Avg. Volume (20D) | 99,187 |
| Open | 6.77 |
| Previous Close | 6.78 |
| Day's Range | 6.65 - 6.90 |
| 52-Week Range | 3.54 - 8.25 |
| Beta | 0.88 |
About DERM
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol DERM
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for DERM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+18.93%
Journey Medical shares are trading higher after th...
Unlock content with
Pro Subscription
10 months ago
+14.22%
Journey Medical shares are trading higher after the company reported better-than-expected Q2 revenue results.
1 month ago · seekingalpha.com
Journey Medical Corporation (DERM) Q1 2025 Earnings Call TranscriptJourney Medical Corporation (NASDAQ:DERM ) Q1 2025 Earnings Conference Call May 14, 2025 4:30 PM ET Company Participants Jaclyn Jaffe - Senior Director, Corporate Operations Claude Maraoui - Co-Founde...
2 months ago · seekingalpha.com
Journey Medical Corporation (DERM) Q4 2024 Earnings Call TranscriptJourney Medical Corporation (NASDAQ:DERM ) Q4 2024 Results Conference Call March 26, 2025 4:30 PM ET Company Participants Jaclyn Jaffe - Senior Director, Corporate Operations Claude Maraoui - Co-Found...
